Cardiogenesis (Irvine, Califonrnia), a developer of surgical products for transmyocardial revascularization (TMR) reported FDA approval of its PEARL (Port Enabled Angina Relief using Laser) 5.0 Robotic Delivery System.
At press time … Cardiogenesis wins approval for PEARL TMR hand piece
January 2, 2015